AHA21 | Scientific Sessions

Screenshot 2021 11 02 130142

Antiplatelet Therapy in Patients With Coronary Artery Disease and Acute Ischemic Stroke/Transient Ischemic Attack

Experts will discuss reducing ischemic and bleeding risk with antiplatelet therapy in patients with CAD, and explain the evidence for DAPT in acute ischemic stroke/TIA and the need for its early use in appropriate individuals

Getty Images 1180201381

Join the Scientific Sessions 2022 Scavenger Hunt

Live Meeting Image

Member Connect

P104 Steven Botts Image

Members Connect: ERG Governs Chromatin Accessibility in Aortic Endothelial Cells

Pres Address Lloyd Jones2

Watch: #AHA21 recap and look ahead

Getty Images 1301907602

Mark your calendar for #AHA22

Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD

Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption

Screening for Kidney Disease to Reduce CVD Risk

Screening for Kidney Disease to Reduce CVD Risk

uACR and eGFR testing are the first step.

Lbs02 Group Blood Patel

Update on local and global hypertension science

Late-breaking science uncovers findings about hypertension.

Getty Images 1219980553 61849bc953192

Read all about #AHA21 in your daily coverage

(from left to right): Brahmajee K. Nallamothu, MD, MPH, FAHA, Rhoda Au, PhD, Seth Martin, MD, MHS, FAHA, and Andrea Beaton, MD, FAHA

QCOR at Sessions: mHealth strategies could help treat CVD around the world

(from left to right, top to bottom rows): Corey E. Ventetuolo, MD, MS, Magdi Yacoub, OM, FRS, Karen Joynt Maddox, MD, MPH, FAHA, Gregory Lewis, MD, Marco Guazzi, MD, PhD, FAHA, Ana Macumbi, MD, PhD, FESC, Mark T. Gladwin, MD, FAHA, and William Bain, MD

The shifting profile of cardiopulmonary COVID-19 survivors

Cardiology community assesses current data and the unknown.

(from left to right): Jonathan P. Piccini, MD, MHS, FAHA, and Steven A. Lubitz, MD, MPH, FAHA

Late-Breaking Science: New information in cardiac disease

Information overload: Striving to improve care delivery through digital health and automated data.

(from left to right): Nasrien E. Ibrahim, MD, Stefan D. Anker, MD, PhD, and Clyde W. Yancy, MD, MSc, FAHA

The latest science in heart failure

Four presenters build on the foundation of treatment and show advances in heart failure therapy.

(From left to right): Danielle Belardo, MD, Rafael Diaz, MD, and Christie Mitchell Ballantyne, MD, FAHA

Trials’ results highlight the potential for fish oil to fight COVID-19 and MK-0616 to lower cholesterol

(left to right): Jacqueline E. Tamis-Holland, MD, and Jane Armitage, FRCP, FFPH, OBE

New drugs, indications in cardiovascular disease

Researchers present research regarding aspirin and dementia, early P2Y12 inhibitors, ticagrelor reversal agent and oral factor XIa.

Getty Images 1221860679

We want your feedback

2021 11 14 21 05 31

Read Monday's #AHA21 daily coverage

Read Day 3 coverage

Evan Dale Abel, MD, and Katherine R. Tuttle, MD

Treatments highlighted for reducing diabetes-related heart failure and chronic kidney disease

Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD

Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption

2021 11 14 13 33 42

QCOR at Sessions

Newsletter Card Combination

Industry Events | Learning Studios and Industry Symposia for Monday

AHA unveils first chest pain guidelines

Newsletter Card Late Breaking

Monday's Late-Breaking Science presentations

Keila Lopez, MD, MPH

Can technology put some patients at a health care disadvantage?

AHA President Donald M. Lloyd-Jones, MD, ScM, FAHA, introduces a fourth layer to the Prevention Pyramid.

Lewis A. Conner Presidential Lecture champions primordial prevention and health equity

hands showing global collaboration

Global, collaborative community is needed to optimize cardiovascular outcomes